329 related articles for article (PubMed ID: 28457030)
1. Evaluation of Effect of Vitamin D Deficiency on Anemia and Erythropoietin Hyporesponsiveness in Patients of Chronic Kidney Disease.
Nand N; Mittal R
J Assoc Physicians India; 2017 Feb; 65(2):38-42. PubMed ID: 28457030
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Effect of Ascorbic Acid on Ferritin and Erythropoietin Resistance in Patients of Chronic Kidney Disease.
Nand N; Deshmukh AR; Mittal R
J Assoc Physicians India; 2017 Jul; 65(7):32-36. PubMed ID: 28792166
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients.
Kumar VA; Kujubu DA; Sim JJ; Rasgon SA; Yang PS
J Nephrol; 2011; 24(1):98-105. PubMed ID: 20563998
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
5. Role of ACE and IL-1β Gene Polymorphisms in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia.
Nand N; Deshmukh AR; Joshi S; Sachdeva MP; Sakthivel
J Assoc Physicians India; 2017 Feb; 65(2):32-36. PubMed ID: 28457029
[TBL] [Abstract][Full Text] [Related]
6. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
[TBL] [Abstract][Full Text] [Related]
8. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
9. Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5.
Rianthavorn P; Boonyapapong P
Pediatr Nephrol; 2013 Aug; 28(8):1261-6. PubMed ID: 23420502
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional study.
Tanaka S; Kitamura H; Tsuruya K; Kitazono T; Nakano T;
Clin Exp Nephrol; 2022 Sep; 26(9):867-879. PubMed ID: 35507237
[TBL] [Abstract][Full Text] [Related]
11. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2007; 39(3):935-40. PubMed ID: 17534732
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effects of Pegylated Erythropoietin and Darbepoetin Alfa on Erythropoietin Hyporesponsive Anemia of Patients with Chronic Kidney Disease on Maintenance Hemodialysis.
Nand N; Nandan R; Jain D
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781656
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.
Santos EJF; Hortegal EV; Serra HO; Lages JS; Salgado-Filho N; Dos Santos AM
Braz J Med Biol Res; 2018; 51(7):e7288. PubMed ID: 29742267
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Effect of Statins on Erythropoietin Resistance in Patients of Chronic Kidney Disease on Maintenance Haemodialysis.
Nand N; Brijlal ; Mittal A
J Assoc Physicians India; 2018 Dec; 66(12):29-32. PubMed ID: 31313547
[TBL] [Abstract][Full Text] [Related]
15. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.
Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086
[TBL] [Abstract][Full Text] [Related]
16. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
[TBL] [Abstract][Full Text] [Related]
17. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
Taylor JE; Peat N; Porter C; Morgan AG
Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
[TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
19. Factors Related to Erythropoietin Hyporesponsiveness in Peritoneal Dialysis Patients with Anemia.
Makruasi N; Changsirikulchai S; Janma J; Rattanamongkolgul S
J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S48-S52. PubMed ID: 29901907
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.
Guerrero-Riscos MÁ; Montes-Delgado R; Seda-Guzmán M; Praena-Fernández JM
Nefrologia; 2012 May; 32(3):343-52. PubMed ID: 22535158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
